Vitamin K and metabolic bone disease

scientific article published on December 1998

Vitamin K and metabolic bone disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/JCP.51.12.943A
P932PMC publication ID501035
P698PubMed publication ID10070341
P5875ResearchGate publication ID13221179

P2093author name stringReynolds TM
P2860cites workAlpha-methyl ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat hepatoma cells in cultureQ35002041
Physiology of the natural polyamines putrescine, spermidine and spermineQ36582243
Vitamin K and metabolic bone diseaseQ37223229
Vitamin K-Dependent Formation of γ-Carboxyglutamic AcidQ39687153
Physiological aspects of ornithine decarboxylaseQ40111071
Hip fracture patients may be vitamin B6 deficient. Controlled study of serum pyridoxal-5'-phosphateQ48399366
Putrescine may be a natural stimulator of glucose-6-phosphate dehydrogenaseQ69513367
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectvitamin KQ182338
(E)-phytonadioneQ186093
P304page(s)943
P577publication date1998-12-01
P1433published inJournal of Clinical PathologyQ6294965
P1476titleVitamin K and metabolic bone disease
P478volume51

Search more.